Table 1 General information and outcomes of patients in this study.
General information | |||||||
Total 41 cases; 20 M/21 F | |||||||
Age: median 47 y (range: 12–78 y) | |||||||
Survival/follow-up: median 58 m (range: 1–242 m) |
Diseases | Outcomes | ||||||
CMR (n = 6) | MMR (n = 8) | CCyR (n = 4) | PCrR (n = 5) | R (n = 4) | D (n = 11) | UN (n = 3) | |
CML (n = 41) | |||||||
CML-CP (n = 31) | 6 | 8 | 4 | 5 | 3 | 2a | 3 |
CML-AP (n = 1) | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
CML-BP (n = 9) | 0 | 0 | 0 | 0 | 1 | 8 | 0 |